Search Results 51-60 of 8289 for TNF
... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...
TNF-related apoptosis-inducing ligand (TRAIL) short, an antagonistic TRAIL splice variant. Casp8p41, a fragment of caspase-8 that is produced through the ...
The research team discovered that increased activity of the alternative NF-kB pathway results from suppression of TNF receptor-associated factor 2, or TRAF2.
In addition to analyzing patient samples, we are using animal models to study the cytokines associated with seizures. That work focuses primarily on TNF because ...
Combination Therapy: Anti-TNF Combination Therapy Group (approximately 40-50% of the group): on anti-TNF therapy as described above along with either 15mg ...
... TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
A maximum of approximately 80% of subjects with any prior anti-TNF agent use will be allowed in the study. At the end of the double blind period, subjects ...
Anti-TNF naïve; or Has initiated only one anti-TNF treatment including participants with inadequate response to the anti-TNF; Note: participants who ...
A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch. Am J Gastroenterol. 2025 Jun 25 Epub ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.